Migraine With Or Without Aura Susceptibility To 5 C1843771
This condition refers to an inherited tendency toward migraines that may or may not include warning symptoms like visual disturbances. Both adults and children can be affected. Management focuses on avoiding triggers, using preventive drugs, and treating acute episodes.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Headache
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Photophobia
(neurologic)Aura
(neurologic)Vomiting
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Sleep hygiene and stress management
Establish consistent sleep patterns with regular bedtimes and wake times. Incorporate stress-reduction techniques such as mindfulness meditation, deep breathing exercises, and progressive muscle relaxation to reduce migraine frequency and severity.
Migraine trigger identification and avoidance
Maintain a food diary to identify personal dietary triggers such as aged cheeses, processed meats, caffeine, alcohol, and artificial sweeteners. A structured elimination diet can help reduce migraine frequency by avoiding individual triggers.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Migraine With Or Without Aura Susceptibility To 5 C1843771?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd Edition. Cephalalgia. 2018;38(1):1-211.
Puledda F, Messina R, Goadsby PJ. Migraine: a narrative review. Lancet Neurol. 2022;21(6):501-514.
Hou M, Xie JF, Kong XP, et al. Calcitonin gene-related peptide monoclonal antibodies for migraine prophylaxis: a meta-analysis of randomized controlled trials. J Headache Pain. 2021;22(1):156.
Dodick DW, Ashina M, Brandes JL, et al. ARCade in Migraine Prevention 1: a randomized, double-blind, placebo-controlled study of erenumab in patients with chronic migraine. Cephalalgia. 2020;40(10):1025-1039.
Medication Comparisons
Compare medications used to treat Migraine With Or Without Aura Susceptibility To 5 C1843771. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy